VJOncology Podcast

Over the last decades, systemic therapy for patients with early-stage breast cancer has undergone remarkable enhancements, with the objectives and structures of neoadjuvant clinical trials continuously developing. In this podcast, we are joined by Sara Tolaney, MD, MPH, Dana-Farber Cancer Institute, Boston, MA, Michael Gnant, MD, FACS, FEBS, Medical University of Vienna, Vienna, Austria, Hope S. R...

Cancer plays a substantial role in worldwide mortality, accounting for approximately 9.3 million deaths each year. Despite considerable strides made over recent decades, the challenge of delivering personalized care persists. In an effort to mitigate this, the integration of artificial intelligence (AI) tools has been suggested across various realms within the field of oncology. The applications o...

Prostate cancer stands as the most frequently detected malignant condition among men, ranking as the second primary contributor to cancer-linked fatalities in Western society. While localized prostate cancer can be addressed through various efficient treatments, nearly all patients eventually advance to the state of incurable metastatic castration-resistant prostate cancer. Given the substantial t...

In this latest episode from VJOncology, join us as we explore the latest news in mesothelioma research with three distinguished speakers. Anthony Chalmers, MD, University of Glasgow, Glasgow, UK, Dean Fennell, MBBS, PhD, FRCP, University Hospitals of Leicester NHS Trust, Leicester, UK, and Riyaz Shah, BSc(Hons), MBBS, FRCP, PhD, Kent Oncology Centre, UK. Discover the Phase II SYSTEMS-2 trial's pot...

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in solid tumors, as well as associate...

The ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2023 brought together world-renowned experts in oncology to present and discuss the latest advances in gastrointestinal cancer. In this podcast, we hear from leading healthcare professionals as they provide an overview of highlights from this year’s meeting. We will be joined by Philip Philip (Wayne State University School of Medicine/Henr...

In this podcast we’ll be covering some of the latest updates in immunotherapy for head and neck cancer. Ezra Cohen, MD, FRCPSC, FASCO, Moores Cancer Center at UC San Diego Health, San Diego, CA, discusses the clinical activity of petosemtamab, a bispecific antibody targeting EGFR and LGR5, in patients with head and neck squamous carcinoma (HNSCC). Nabil Saba, MD, FACP, Winship Cancer Institute of...

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in solid tumors, as well as associate...

In this episode, we will be covering highly anticipated updated in urothelial carcinoma presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2023 in Chicago, IL. We are joined by Arlene Siefker-Radtke, MD of The University of Texas MD Anderson Cancer Center. Professor Siefker-Radtke is a leading expert in genitourinary cancer and will be sharing insights and updates from th...

The American Society of Clinical Oncology Annual Meeting 2023 brought together thousands of experts in oncology to hear new data and discuss how to improve the diagnosis and treatment of patients with cancer. In this podcast, we hear from leading experts as they discuss some of the most groundbreaking trials from this year’s meeting. We will be joined by Yohann Loriot (Gustave Roussy, Villejuif, F...

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in solid tumors, as well as associate...

The 5th International Workshop on CAR-T (iwCAR-T) took place in Scottsdale, AZ, on 14 – 16 April 2023, and brought together world-leading experts in CAR-T therapy as they discussed the latest in the field. In this podcast series, you will gain an insight into the sessions that took place at this year’s meeting, which covered the latest updates in CAR-T therapy in solid tumors, as well as associate...

  Experts Julian Molina (Mayo Clinic, Rochester, MN), Mathew Angelos (University of Pennsylvania, Philadelphia, PA), and Sebastian Kobold (Ludwig-Maximilians-University of Munich, Munich, Germany) bring you updates live from the International Workshop of CAR-T and Immunotherapies (iwCART) 2023. In considering the latest research and trials in the field of CAR T-cell therapy and the challenges asso...

In this podcast, we’ll be covering highlights from the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL, including personalized mRNA and neoantigen vaccines, nivolumab with the standard of care in prostate cancer, and BGB-3245, a novel RAF dimer inhibitor, in solid tumors. Hear from Jeffrey Weber, NYU Langone Perlmutter Cancer Center, NY, Mansi Saxena, Icahn Schoo...

In this podcast, we’ll be discussing the use of liquid biopsy in lung cancer, with Professor Klaus Pantel of University Medical Center Hamburg-Eppendorf, in Hamburg, Germany. At the European Lung Cancer Congress (ELCC) 2023, we spoke with Professor Pantel about possible areas where liquid biopsy could be useful, such as clinical trial recruitment, as well as practical considerations for the use of...

In this podcast, Icro Meattini (University of Florence, Florence, Italy) and Orit Kaidar-Person (Sheba Medical Center, Ramat Gan, Israel) discuss updates and controversies in the axillary management of breast cancer, live at the St Gallen Breast Cancer Consensus 2023.

In this podcast, hear from GU cancer experts Sophia Kamran (Massachusetts General Hospital and Harvard Medical School, Boston, MA), Himanshu Nagar (Weill Cornell Medicine and New York Presbyterian, New York City, NY), and Neha Vapiwala (Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA) as they discuss the highlights in radiation oncology for GU cancers at the ASCO GU Cance...

The St Gallen Breast Cancer Congress took place on the 15-18 March 2023. Leading researchers and experts were brought together in Vienna, Austria, to discuss and debate the most important updates in breast cancer. In this podcast, we’ll run through research updates spanning from early treatment to post-adjuvant therapy and a taste of the ethical considerations involved in recruiting for clinical t...

In this episode, join GU cancer experts Scott Tagawa (Weill Cornell Medicine and New York Presbyterian, New York City, NY), Karie Runcie (Columbia University Irving Medical Center, New York City, NY), and Tanya Dorff (City of Hope Comprehensive Cancer Center, Duarte, CA) as they discuss the most important clinical trial data for prostate, bladder, and kidney cancer at the ASCO GU Cancers Symposium...

In this episode, we'll hear from Marcia Hall, Eric Pujade-Lauraine, and Mansoor Raza Mirza, who will share their expertise and insights on the latest developments in gynecological cancer research and treatment from ESMO Gynae 2023. First, we will hear about a study exploring the use of circulating tumor cells as a potential biomarker for predicting response to therapy. Dr Hall discusses how this s...

In this podcast we’ll hear from experts in GU cancer on some of the most exciting clinical trial data in kidney cancer as well as some of the latest developments in rare tumors presented at the 2023 ASCO Genitourinary Cancers congress. We will be joined by Thomas Powles, MBBS, MRCP, MD, Barts Cancer Institute, London, UK, Michael Atkins, MD, Lombardi Comprehensive Cancer Center, Washington DC, Tal...

In this episode, we’ll be hearing from GU cancer experts about some of the biggest prostate cancer data presented at the ASCO Genitourinary Cancers Symposium 2023, including TRITON3, CheckMate650, and FORMULA-509. We’ll also be hearing perspectives on some of the hot topics in the field, such as treatment sequencing and combination therapies, unanswered questions for the use of PSMA PET in the sta...

In this podcast, we dive deep into some of the most exciting advances in bladder cancer research that were presented at the 2023 ASCO Genitourinary Cancers congress. We will hear from Kyle Rose, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, Robert Huddart, PhD, FRCR, MRCP, MBBS, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK, Aristotelis Bamias, MD,...

In this podcast, we will explore approaches to non-small cell lung cancer (NSCLC) with and without targetable mutations. NSCLC is the most common type of lung cancer, and while significant strides have been made in its management, there are still areas of unmet need. Our speakers, Luis Raez, MD, FACP, FCCP, from Memorial Healthcare System in Pembroke Pines, FL, Melissa Johnson, MD, Sarah Cannon Re...

Whilst CAR-T cell therapies have found considerable success in targeting hematological malignancies, major hurdles remain in the solid tumor space. Novel targets such as claudin 18.2 (CLDN18.2), and innovative strategies have led to encouraging results in solid tumors. In this podcast, we will hear from Gregory P. Botta, MD, PhD, UC San Diego Medical Center, San Diego, CA, Jon Amund Kyte, MD, PhD,...